Increased Muscle Proteasome Activity Correlates With Disease Severity in Gastric Cancer Patients
To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients. Muscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Incre...
Saved in:
Published in | Annals of surgery Vol. 237; no. 3; pp. 384 - 389 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott
01.03.2003
|
Subjects | |
Online Access | Get full text |
ISSN | 0003-4932 1528-1140 |
DOI | 10.1097/01.SLA.0000055225.96357.71 |
Cover
Loading…
Abstract | To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients.
Muscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Increased muscle ubiquitin mRNA levels have been previously shown in gastric cancer patients, suggesting that this proteolytic system might be modulated also in human cancer.
Biopsies of the rectus abdominis muscle were obtained intraoperatively from 23 gastric cancer patients and 14 subjects undergoing surgery for benign abdominal diseases, and muscle ubiquitin mRNA expression and proteasome proteolytic activities were assessed.
Muscle ubiquitin mRNA was hyperexpressed in gastric cancer patients compared to controls. In parallel, three proteasome proteolytic activities (CTL, chymotrypsin-like; TL, trypsin-like; PGP, peptidyl-glutamyl-peptidase) significantly increased in gastric cancer patients with respect to controls. Advanced tumor stage, poor nutritional status, and age more than 50 years were associated with significantly higher CTL activity but had no influence on TL and PGP activity.
These results confirm the involvement of the ubiquitin-proteasome proteolytic system in the pathogenesis of muscle protein hypercatabolism in cancer cachexia. The observation that perturbations of this pathway in gastric cancer patients occur even before clinical evidence of body wasting supports the thinking that specific pharmacologic and metabolic approaches aimed at counteracting the upregulation of this pathway should be undertaken as early as cancer is diagnosed. |
---|---|
AbstractList | To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients.OBJECTIVETo investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients.Muscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Increased muscle ubiquitin mRNA levels have been previously shown in gastric cancer patients, suggesting that this proteolytic system might be modulated also in human cancer.SUMMARY BACKGROUND DATAMuscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Increased muscle ubiquitin mRNA levels have been previously shown in gastric cancer patients, suggesting that this proteolytic system might be modulated also in human cancer.Biopsies of the rectus abdominis muscle were obtained intraoperatively from 23 gastric cancer patients and 14 subjects undergoing surgery for benign abdominal diseases, and muscle ubiquitin mRNA expression and proteasome proteolytic activities were assessed.METHODSBiopsies of the rectus abdominis muscle were obtained intraoperatively from 23 gastric cancer patients and 14 subjects undergoing surgery for benign abdominal diseases, and muscle ubiquitin mRNA expression and proteasome proteolytic activities were assessed.Muscle ubiquitin mRNA was hyperexpressed in gastric cancer patients compared to controls. In parallel, three proteasome proteolytic activities (CTL, chymotrypsin-like; TL, trypsin-like; PGP, peptidyl-glutamyl-peptidase) significantly increased in gastric cancer patients with respect to controls. Advanced tumor stage, poor nutritional status, and age more than 50 years were associated with significantly higher CTL activity but had no influence on TL and PGP activity.RESULTSMuscle ubiquitin mRNA was hyperexpressed in gastric cancer patients compared to controls. In parallel, three proteasome proteolytic activities (CTL, chymotrypsin-like; TL, trypsin-like; PGP, peptidyl-glutamyl-peptidase) significantly increased in gastric cancer patients with respect to controls. Advanced tumor stage, poor nutritional status, and age more than 50 years were associated with significantly higher CTL activity but had no influence on TL and PGP activity.These results confirm the involvement of the ubiquitin-proteasome proteolytic system in the pathogenesis of muscle protein hypercatabolism in cancer cachexia. The observation that perturbations of this pathway in gastric cancer patients occur even before clinical evidence of body wasting supports the thinking that specific pharmacologic and metabolic approaches aimed at counteracting the upregulation of this pathway should be undertaken as early as cancer is diagnosed.CONCLUSIONSThese results confirm the involvement of the ubiquitin-proteasome proteolytic system in the pathogenesis of muscle protein hypercatabolism in cancer cachexia. The observation that perturbations of this pathway in gastric cancer patients occur even before clinical evidence of body wasting supports the thinking that specific pharmacologic and metabolic approaches aimed at counteracting the upregulation of this pathway should be undertaken as early as cancer is diagnosed. To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients. Muscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Increased muscle ubiquitin mRNA levels have been previously shown in gastric cancer patients, suggesting that this proteolytic system might be modulated also in human cancer. Biopsies of the rectus abdominis muscle were obtained intraoperatively from 23 gastric cancer patients and 14 subjects undergoing surgery for benign abdominal diseases, and muscle ubiquitin mRNA expression and proteasome proteolytic activities were assessed. Muscle ubiquitin mRNA was hyperexpressed in gastric cancer patients compared to controls. In parallel, three proteasome proteolytic activities (CTL, chymotrypsin-like; TL, trypsin-like; PGP, peptidyl-glutamyl-peptidase) significantly increased in gastric cancer patients with respect to controls. Advanced tumor stage, poor nutritional status, and age more than 50 years were associated with significantly higher CTL activity but had no influence on TL and PGP activity. These results confirm the involvement of the ubiquitin-proteasome proteolytic system in the pathogenesis of muscle protein hypercatabolism in cancer cachexia. The observation that perturbations of this pathway in gastric cancer patients occur even before clinical evidence of body wasting supports the thinking that specific pharmacologic and metabolic approaches aimed at counteracting the upregulation of this pathway should be undertaken as early as cancer is diagnosed. |
Author | Bonelli, Gabriella Baccino, Francesco Maria Fanelli, Filippo Rossi Doglietto, Giovanni Battista Bossola, Maurizio Costelli, Paola Grieco, Gabriella Muscaritoli, Maurizio Pacelli, Fabio |
AuthorAffiliation | From Istituto di Clinica Chirurgica, Università Cattolica del Sacro Cuore, Roma; †Dipartimento di Medicina Clinica, Università ‘La Sapienza,’ Roma; ‡Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino; and §Centro CNR di Immunogenetica ed Oncologia Sperimentale, Torino, Italy |
AuthorAffiliation_xml | – name: From Istituto di Clinica Chirurgica, Università Cattolica del Sacro Cuore, Roma; †Dipartimento di Medicina Clinica, Università ‘La Sapienza,’ Roma; ‡Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino; and §Centro CNR di Immunogenetica ed Oncologia Sperimentale, Torino, Italy |
Author_xml | – sequence: 1 givenname: Maurizio surname: Bossola fullname: Bossola, Maurizio – sequence: 2 givenname: Maurizio surname: Muscaritoli fullname: Muscaritoli, Maurizio – sequence: 3 givenname: Paola surname: Costelli fullname: Costelli, Paola – sequence: 4 givenname: Gabriella surname: Grieco fullname: Grieco, Gabriella – sequence: 5 givenname: Gabriella surname: Bonelli fullname: Bonelli, Gabriella – sequence: 6 givenname: Fabio surname: Pacelli fullname: Pacelli, Fabio – sequence: 7 givenname: Filippo Rossi surname: Fanelli fullname: Fanelli, Filippo Rossi – sequence: 8 givenname: Giovanni Battista surname: Doglietto fullname: Doglietto, Giovanni Battista – sequence: 9 givenname: Francesco Maria surname: Baccino fullname: Baccino, Francesco Maria |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14639795$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12616123$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkVFvFCEUhYmpsdvqXzDERN925A7DMPhg3Ky1Nlljk2p8RBbuWMzsUIHdpP--jF1d9UkSQsL97jlwzwk5GsOIhDwDVgFT8iWD6mq1qNi0hKhrUamWC1lJeEBmIOpuDtCwIzIrdT5vFK-PyUlK3xmDpmPyETmGuoUWaj4jXy9GG9EkdPTDNtkB6WUMuVyEDdKFzX7n8y1dhhhxMBkT_eLzNX3r09RDr3CHcQL8SM9NytFbujSjxUgvTfY45vSYPOzNkPDJ_jwln9-dfVq-n68-nl8sF6u5bbiEuXBNZ51irkamemY7q5RE3nNQonaqdy0IAVxY00gp1r2RTri1dU1bY1c2PyWv73VvtusNOlu8oxn0TfQbE291MF7_XRn9tf4WdhoENBygCLzYC8TwY4sp641PFofBjBi2SUvOJOeiK-DTP51-W_waagGe7wGTrBn6WCbi04FrWq6kEoV7dc_ZGFKK2B8QpqekNQNdktaHpPXPpLWcnvvmn2brc5l5mH7nh_-RuAMbP7D1 |
CODEN | ANSUA5 |
CitedBy_id | crossref_primary_10_1177_1099800408317345 crossref_primary_10_1016_j_critrevonc_2005_01_004 crossref_primary_10_1097_SPC_0b013e3283196ac2 crossref_primary_10_1186_s12885_016_2121_8 crossref_primary_10_1158_1078_0432_CCR_11_2133 crossref_primary_10_3945_an_111_001792 crossref_primary_10_1038_s41598_018_36626_3 crossref_primary_10_1002_jcsm_12050 crossref_primary_10_1016_j_bbadis_2008_10_011 crossref_primary_10_1016_j_ejca_2005_07_026 crossref_primary_10_1155_2018_7153610 crossref_primary_10_1016_j_nut_2022_111625 crossref_primary_10_1007_s13539_012_0087_1 crossref_primary_10_3390_biom11010110 crossref_primary_10_1371_journal_pone_0222345 crossref_primary_10_1002_jcsm_13222 crossref_primary_10_1016_j_cyto_2013_05_018 crossref_primary_10_4137_CIN_S8104 crossref_primary_10_1371_journal_pone_0024650 crossref_primary_10_1177_1535370221990322 crossref_primary_10_18632_oncotarget_9779 crossref_primary_10_1002_jcb_20246 crossref_primary_10_1017_S0007114512002358 crossref_primary_10_1016_j_biochi_2019_07_014 crossref_primary_10_1007_s10330_018_0279_9 crossref_primary_10_1002_mus_21893 crossref_primary_10_1002_mus_23798 crossref_primary_10_1002_jcsm_12124 crossref_primary_10_1152_ajpendo_00409_2009 crossref_primary_10_1177_0115426505020004369 crossref_primary_10_1177_1534735418781743 crossref_primary_10_1002_jcsm_12043 crossref_primary_10_1016_j_biocel_2004_10_017 crossref_primary_10_1016_j_semcdb_2015_11_005 crossref_primary_10_4103_apjon_apjon_2126 crossref_primary_10_1096_fj_13_239228 crossref_primary_10_3945_ajcn_113_063859 crossref_primary_10_1016_j_critrevonc_2010_10_004 crossref_primary_10_1097_SLA_0b013e3181a38e71 crossref_primary_10_1186_s13045_023_01454_0 crossref_primary_10_1002_jcsm_12633 crossref_primary_10_1002_mco2_70030 crossref_primary_10_1016_j_biocel_2006_03_015 crossref_primary_10_1016_j_lfs_2016_11_033 crossref_primary_10_1139_apnm_2013_0433 crossref_primary_10_1016_j_clnu_2007_08_014 crossref_primary_10_1016_j_freeradbiomed_2015_12_031 crossref_primary_10_1007_s13539_013_0116_8 crossref_primary_10_1371_journal_pone_0086600 crossref_primary_10_3389_fphys_2019_00041 crossref_primary_10_1007_s10616_022_00538_y crossref_primary_10_3945_ajcn_113_058388 crossref_primary_10_1016_j_cmet_2012_06_011 crossref_primary_10_1152_ajpregu_00104_2006 crossref_primary_10_1097_CCO_0b013e3283479c66 crossref_primary_10_1249_MSS_0000000000001991 crossref_primary_10_1002_mus_23945 crossref_primary_10_1042_CS20060265 crossref_primary_10_1002_hed_23696 crossref_primary_10_3390_cancers14174258 crossref_primary_10_3892_or_2015_3845 crossref_primary_10_1002_jcp_28437 crossref_primary_10_1158_0008_5472_CAN_04_1760 crossref_primary_10_1016_j_clnu_2007_07_004 crossref_primary_10_3390_cancers14020342 crossref_primary_10_1097_SLA_0000000000000628 crossref_primary_10_1016_j_arr_2009_02_001 crossref_primary_10_1093_annonc_mdt551 crossref_primary_10_1177_0115426505020004394 crossref_primary_10_1152_ajpregu_00147_2019 crossref_primary_10_1007_s13539_011_0043_5 crossref_primary_10_18087_cardio_2020_2_n985 crossref_primary_10_1186_s12864_024_10359_2 crossref_primary_10_3389_fcell_2021_719643 crossref_primary_10_3390_ijms22031280 crossref_primary_10_1002_nur_20057 crossref_primary_10_1016_j_semcdb_2015_12_022 crossref_primary_10_1152_physiol_00019_2005 crossref_primary_10_1161_STROKEAHA_114_006258 crossref_primary_10_1016_j_jamda_2008_01_003 crossref_primary_10_1002_nur_20019 crossref_primary_10_1002_mus_21798 crossref_primary_10_1016_j_biocel_2013_05_032 crossref_primary_10_1016_j_ejca_2009_10_008 crossref_primary_10_1177_1758834017698643 crossref_primary_10_3389_fonc_2018_00457 crossref_primary_10_1002_jcsm_12466 crossref_primary_10_1097_01_mco_0000078984_18774_02 |
Cites_doi | 10.1002/ijc.2910610123 10.1042/bj3320315 10.1042/CS20000032 10.1097/00075197-200005000-00003 10.1172/JCI117929 10.1054/bjoc.2001.1879 10.1097/00000658-200101000-00003 10.1172/JCI116897 10.1054/bjoc.2001.1696 10.1016/S0021-9258(19)52451-6 10.1007/s005950050247 10.1172/JCI119513 10.1073/pnas.93.7.2714 10.1042/CS19980092 10.1172/JCI112344 10.1097/00075197-200105000-00003 10.1172/JCI119143 10.1016/0014-5793(94)80290-4 10.1002/(SICI)1098-1128(199703)17:2<139::AID-MED1>3.0.CO;2-0 10.1016/S0039-6060(99)70131-5 10.1016/0003-2697(87)90021-2 10.1016/S0140-6736(87)91850-2 10.1006/bbrc.2001.5209 10.1038/bjc.1993.4 10.1016/S0304-3835(98)00216-X 10.1172/JCI118566 10.1042/bst0150963 10.1096/fasebj.13.11.1435 10.1023/A:1006955832323 10.1006/bbrc.1996.0651 10.1046/j.1365-2362.2000.00751.x |
ContentType | Journal Article |
Copyright | 2003 INIST-CNRS 2003 Lippincott Williams & Wilkins, Inc. |
Copyright_xml | – notice: 2003 INIST-CNRS – notice: 2003 Lippincott Williams & Wilkins, Inc. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1097/01.SLA.0000055225.96357.71 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1528-1140 |
EndPage | 389 |
ExternalDocumentID | PMC1514311 12616123 14639795 10_1097_01_SLA_0000055225_96357_71 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 1J1 23M 2WC 354 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5VS 6J9 71W 77Y 7O~ AAAAV AAAXR AAEJM AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAXQO AAYXX ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPPZ ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHJKT AHOMT AHQNM AHQVU AHRYX AHVBC AI. AIJEX AINUH AJCLO AJIOK AJJEV AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AZFZN BAWUL BOYCO BQLVK BS7 BYPQX C45 CITATION CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FEDTE FL- FW0 GNXGY GQDEL H0~ HLJTE HVGLF HZ~ IH2 IKREB IKYAY IN~ IPNFZ J5H JF7 JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B M18 N4W N9A N~7 N~B N~M O9- OAG OAH OBH OCB OCUKA ODA ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ RPM RXW S4R S4S T8P TAF TEORI TR2 TSPGW UQX V2I VH1 VVN W3M WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YOC ZFV ZGI ZXP ZY1 ZZMQN ~H1 IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c4371-5d48cd90d2e09f0c8c997e3f31952d9fd6155135ca4775bfa7d5dbcd462e862e3 |
ISSN | 0003-4932 |
IngestDate | Thu Aug 21 13:18:40 EDT 2025 Fri Jul 11 02:05:13 EDT 2025 Mon Jul 21 06:03:30 EDT 2025 Mon Jul 21 09:15:02 EDT 2025 Thu Apr 24 23:11:27 EDT 2025 Tue Jul 01 00:23:41 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Stomach Multicatalytic endopeptidase complex Correlation Pathophysiology Enzyme Cachexia Malignant tumor Peptidases Enzymatic activity Digestive diseases Hydrolases Severity score Gastric disease |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4371-5d48cd90d2e09f0c8c997e3f31952d9fd6155135ca4775bfa7d5dbcd462e862e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://doi.org/10.1097/01.SLA.0000055225.96357.71 |
PMID | 12616123 |
PQID | 73073358 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1514311 proquest_miscellaneous_73073358 pubmed_primary_12616123 pascalfrancis_primary_14639795 crossref_primary_10_1097_01_SLA_0000055225_96357_71 crossref_citationtrail_10_1097_01_SLA_0000055225_96357_71 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2003-03-00 |
PublicationDateYYYYMMDD | 2003-03-01 |
PublicationDate_xml | – month: 03 year: 2003 text: 2003-03-00 |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Annals of surgery |
PublicationTitleAlternate | Ann Surg |
PublicationYear | 2003 |
Publisher | Lippincott |
Publisher_xml | – name: Lippincott |
References | Lowry (R21-13-20110409) 1951; 193 Temparis (R22-13-20110409) 1994; 54 Baracos (R23-13-20110409) 1995; 268 DeWys (R2-13-20110409) 1985; 12 Beyette (R20-13-20110409) 1998; 332 Chomczynski (R19-13-20110409) 1987; 162 Tiao (R15-13-20110409) 1997; 99 Saarinen (R40-13-20110409) 1990; 50 Hobler (R33-13-20110409) 1998; 274 Hasselgren (R4-13-20110409) 2001; 233 Jagoe (R18-13-20110409) 2001; 4 Hobler (R27-13-20110409) 1999; 277 Dahlmann (R31-13-20110409) 1987; 15 Argilés (R3-13-20110409) 1999; 14 Adams (R32-13-20110409) 1999; 59 Fang (R28-13-20110409) 2000; 99 Costelli (R1-13-20110409) 2000; 3 Balkwill (R41-13-20110409) 1987; 2 Llovera (R24-13-20110409) 1995; 61 Costelli (R12-13-20110409) 1993; 92 Williams (R5-13-20110409) 1999; 13 Llovera (R13-13-20110409) 1994; 338 Llovera (R8-13-20110409) 1998; 2 Pallares-Trujillo (R7-13-20110409) 1998; 17 Llovera (R16-13-20110409) 1996; 221 Bailey (R9-13-20110409) 1996; 97 May (R10-13-20110409) 1986; 77 Mansoor (R14-13-20110409) 1996; 93 Bossola (R36-13-20110409) 2000; 30 Combaret (R42-13-20110409) 1999; 26 Tessitore (R38-13-20110409) 1993; 67 Whitehouse (R29-13-20110409) 2001; 285 Tawa (R35-13-20110409) 1997; 100 Bossola (R17-13-20110409) 2001; 280 Llovera (R39-13-20110409) 1998; 133 Costelli (R6-13-20110409) 2001; 84 Williams (R26-13-20110409) 1999; 126 Costelli (R30-13-20110409) 2000; 19 Lorite (R25-13-20110409) 2001; 85 Costelli (R11-13-20110409) 1995; 95 Fang (R34-13-20110409) 1998; 95 Shibata (R37-13-20110409) 1998; 28 |
References_xml | – volume: 50 start-page: 592 year: 1990 ident: R40-13-20110409 publication-title: Cancer Res – volume: 54 start-page: 5568 year: 1994 ident: R22-13-20110409 publication-title: Cancer Res – volume: 61 start-page: 138 year: 1995 ident: R24-13-20110409 publication-title: Int J Cancer doi: 10.1002/ijc.2910610123 – volume: 19 start-page: 30 year: 2000 ident: R30-13-20110409 publication-title: Nutrition – volume: 332 start-page: 315 year: 1998 ident: R20-13-20110409 publication-title: Biochem J doi: 10.1042/bj3320315 – volume: 99 start-page: 181 year: 2000 ident: R28-13-20110409 publication-title: Clin Sci doi: 10.1042/CS20000032 – volume: 3 start-page: 177 year: 2000 ident: R1-13-20110409 publication-title: Curr Opin Clin Nutrition Metab doi: 10.1097/00075197-200005000-00003 – volume: 95 start-page: 2367 year: 1995 ident: R11-13-20110409 publication-title: J Clin Invest doi: 10.1172/JCI117929 – volume: 85 start-page: 297 year: 2001 ident: R25-13-20110409 publication-title: Br J Cancer doi: 10.1054/bjoc.2001.1879 – volume: 233 start-page: 9 year: 2001 ident: R4-13-20110409 publication-title: Ann Surg doi: 10.1097/00000658-200101000-00003 – volume: 92 start-page: 2783 year: 1993 ident: R12-13-20110409 publication-title: J Clin Invest doi: 10.1172/JCI116897 – volume: 84 start-page: 946 year: 2001 ident: R6-13-20110409 publication-title: Br J Cancer doi: 10.1054/bjoc.2001.1696 – volume: 193 start-page: 265 year: 1951 ident: R21-13-20110409 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)52451-6 – volume: 28 start-page: 884 year: 1998 ident: R37-13-20110409 publication-title: Surg Today doi: 10.1007/s005950050247 – volume: 12 start-page: 452 year: 1985 ident: R2-13-20110409 publication-title: Semin Oncol – volume: 100 start-page: 197 year: 1997 ident: R35-13-20110409 publication-title: J Clin Invest doi: 10.1172/JCI119513 – volume: 93 start-page: 2714 year: 1996 ident: R14-13-20110409 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.93.7.2714 – volume: 95 start-page: 225 year: 1998 ident: R34-13-20110409 publication-title: Clin Sci doi: 10.1042/CS19980092 – volume: 77 start-page: 614 year: 1986 ident: R10-13-20110409 publication-title: J Clin Invest doi: 10.1172/JCI112344 – volume: 4 start-page: 183 year: 2001 ident: R18-13-20110409 publication-title: Curr Opin Clin Nutr Metab Care doi: 10.1097/00075197-200105000-00003 – volume: 99 start-page: 163 year: 1997 ident: R15-13-20110409 publication-title: J Clin Invest doi: 10.1172/JCI119143 – volume: 338 start-page: 311 year: 1994 ident: R13-13-20110409 publication-title: FEBS Lett doi: 10.1016/0014-5793(94)80290-4 – volume: 274 start-page: R30 year: 1998 ident: R33-13-20110409 publication-title: Am J Physiol – volume: 17 start-page: 139 year: 1998 ident: R7-13-20110409 publication-title: Med Res Rev doi: 10.1002/(SICI)1098-1128(199703)17:2<139::AID-MED1>3.0.CO;2-0 – volume: 277 start-page: R434 year: 1999 ident: R27-13-20110409 publication-title: Am J Physiol – volume: 126 start-page: 744 year: 1999 ident: R26-13-20110409 publication-title: Surgery doi: 10.1016/S0039-6060(99)70131-5 – volume: 162 start-page: 156 year: 1987 ident: R19-13-20110409 publication-title: Anal Biochem doi: 10.1016/0003-2697(87)90021-2 – volume: 2 start-page: 1229 year: 1987 ident: R41-13-20110409 publication-title: Lancet doi: 10.1016/S0140-6736(87)91850-2 – volume: 2 start-page: 69 year: 1998 ident: R8-13-20110409 publication-title: Int J Mol Med – volume: 285 start-page: 598 year: 2001 ident: R29-13-20110409 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.2001.5209 – volume: 67 start-page: 16 year: 1993 ident: R38-13-20110409 publication-title: Br J Cancer doi: 10.1038/bjc.1993.4 – volume: 133 start-page: 83 year: 1998 ident: R39-13-20110409 publication-title: Cancer Lett doi: 10.1016/S0304-3835(98)00216-X – volume: 97 start-page: 1447 year: 1996 ident: R9-13-20110409 publication-title: J Clin Invest doi: 10.1172/JCI118566 – volume: 15 start-page: 963 year: 1987 ident: R31-13-20110409 publication-title: Biochem Soc Trans doi: 10.1042/bst0150963 – volume: 13 start-page: 1435 year: 1999 ident: R5-13-20110409 publication-title: FASEB J doi: 10.1096/fasebj.13.11.1435 – volume: 280 start-page: R1518 year: 2001 ident: R17-13-20110409 publication-title: Am J Physiol – volume: 59 start-page: 2615 year: 1999 ident: R32-13-20110409 publication-title: Cancer Res – volume: 26 start-page: 95 year: 1999 ident: R42-13-20110409 publication-title: Mol Biol Rep doi: 10.1023/A:1006955832323 – volume: 221 start-page: 653 year: 1996 ident: R16-13-20110409 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1996.0651 – volume: 30 start-page: 1107 year: 2000 ident: R36-13-20110409 publication-title: Eur J Clin Invest doi: 10.1046/j.1365-2362.2000.00751.x – volume: 268 start-page: E996 year: 1995 ident: R23-13-20110409 publication-title: Am J Physiol – volume: 14 start-page: 479 year: 1999 ident: R3-13-20110409 publication-title: Int J Oncol |
SSID | ssj0014807 |
Score | 2.156475 |
Snippet | To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients.
Muscle wasting in... To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients.OBJECTIVETo... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 384 |
SubjectTerms | Biological and medical sciences Biopsy Chymotrypsin - metabolism Cysteine Endopeptidases - metabolism Endopeptidases - metabolism Female Gastroenterology. Liver. Pancreas. Abdomen Gene Expression Humans In Vitro Techniques Male Medical sciences Middle Aged Multienzyme Complexes - metabolism Nutritional Status Original Proteasome Endopeptidase Complex Rectus Abdominis - metabolism RNA, Messenger - metabolism Stomach Neoplasms - metabolism Stomach Neoplasms - pathology Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Trypsin - metabolism Tumors Ubiquitin - genetics Ubiquitin - metabolism Weight Loss |
Title | Increased Muscle Proteasome Activity Correlates With Disease Severity in Gastric Cancer Patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/12616123 https://www.proquest.com/docview/73073358 https://pubmed.ncbi.nlm.nih.gov/PMC1514311 |
Volume | 237 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZguSAhBOJVHosP3FapGj-S-rha9gGUBYlW6i04tgOVssmqaS_765mJ82iWRSxcoiiumzbfF3vGnvmGkHeRdlZnDNxUIVwgMnjnlItUYJXgXFvUA8Hk5M_n0dlCfFzKZR_KW2eXbNKxuboxr-R_UIVrgCtmyf4Dst2XwgU4B3zhCAjD8VYYw8uNMeVgM15sK2g7qFUXdFVeeJGMui6EwfobOZqUftG12ZI5gCnRYeU6XPH4obF8h8EQMOPWrdhqtWu59krL1U4mdR1oiP9S-8Sf7Xp15SO7PIqVAV98U_oc7OvNR5hgkvu2r7rMuxniFPx3U6_hnuoUzvOmqV2d4H14Vjfi8kAoPhhxmdd5aajFd8ZP7uvF_Taue73gSTj-Njv0kpMSDEc5ViinN_ZFXIZi2udfkpPFbJbMj5fzu-QeAy8CK3u8__Cp22Rqs-nbn9hq0qKm5x_vNLBfHlxqeI555mug3OSkXI-13TFe5o_Iw8broIeeQo_JHVc8Id87-lBPH9rTh7b0oT19KNKHNvShLX3oqqANfainD23p85QsTo7nR2dBU3AjMILHYSCtmBqrJpa5icomZmqUih3PYJiWzKrMRnU9IGm0iGOZZjq20qbGiog58Iwdf0b2irJwLwjVVk-nSqecMyVSLbVRmrlUTFKWpTxkI6Lax5iYRo0ei6LkSRcVESYAQdJDkNQQJHE4Irzre-k1WW7Va3-AVt9V1JvbckTetvAlMMbixpkuXLmtkhgnQi6nI_Lcg9n3ZVGIAkYjEg9g7j6A6u3DlmL1s1ZxD9FVCcOXf73rK3K_f7Nek73NeuvegCW8SfdrPv8CNka2oQ |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+muscle+proteasome+activity+correlates+with+disease+severity+in+gastric+cancer+patients&rft.jtitle=Annals+of+surgery&rft.au=Bossola%2C+Maurizio&rft.au=Muscaritoli%2C+Maurizio&rft.au=Costelli%2C+Paola&rft.au=Grieco%2C+Gabriella&rft.date=2003-03-01&rft.issn=0003-4932&rft.volume=237&rft.issue=3&rft.spage=384&rft_id=info:doi/10.1097%2F01.SLA.0000055225.96357.71&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4932&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4932&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4932&client=summon |